NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

http://www.reportlinker.com/p0479888/Hematology-Reagents-and-Analyzers---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html

Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global hematology market. The report provides market landscape, competitive landscape and market trends information on the hematology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include hemostasis, hematology reagents, immunohematology, haematology rapid tests, hematology analyzers and hematology cell counters.

- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within hematology market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Beckman Coulter, Sysmex Corporation, F. Hoffmann-La Roche Ltd. (Roche), Siemens Healthcare and Abbott Laboratories.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the hematology market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the hematology market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global hematology market and the factors shaping it.

1 Table of contents

1 Table of contents 4

1.1 List of Tables 7

1.2 List of Figures 8

2 Introduction 9

2.1 GlobalData Report Guidance 9

3 Hematology: Device Overview 10

3.1 Hemostasis 10

3.2 Hematology Reagents 10

3.3 Immunohematology 11

3.4 Hematology Rapid Tests 11

3.5 Hematology Analyzers 11

3.6 Hematology Cell Counters 12

4 Disorders Detected using Hematology Diagnostics 13

4.1 Blood Disorders 13

4.1.1 Anemia 13

4.1.2 Leukemia 14

4.1.3 Lymphoma 14

4.1.4 Bleeding and Clotting Disorders 15

5 Hematology: Global Market Characterization 15

5.1 Hematology Market, Global, Revenue ($m), Historic, 2003–2010 15

5.2 Hematology Market, Global, Revenue ($m), Forecast, 2010–2017 16

5.3 Hematology Market, Key Trends 17

5.3.1 Increasing Automation in Laboratories is a Key Trend in the Diagnostic Hematology Market 17

5.3.2 Point of Care Testing and Development of Support Technologies is a Major Trend in Hematology Market 18

5.4 Hematology, Market Dynamics 20

5.4.1 Market Drivers 21

5.5 Market Restraints 27

5.6 Hematology Market, Global, Company Share (%), 2009 29

6 Hematology Market, Segment Analysis 30

6.1 Hemostasis, Global, Revenue ($m), Historic, 2003–2010 30

6.2 Hemostasis, Global, Revenue ($m), Forecast, 2010–2017 31

6.3 Hemostasis, Market Dynamics 32

6.3.1 Market Drivers 32

6.3.2 Market Restraint: High Price and Low Profit Margins of Coagulation Analyzers are the Key Restraints for the Hemostasis Market 32

6.4 Hematology Reagents, Global, Revenue ($m), Historic, 2003–2010 33

6.5 Hematology Reagents, Global, Revenue ($m), Forecast, 2010–2017 34

6.6 Hematology Reagents, Market Dynamics 35

6.6.1 Market Driver: Increasing Number of Installed Automated Hematology Analyzers is Driving the Market of Hematology Reagents 35

6.6.2 Market Restraint: Increasing Usage of Sensor based POC Blood Analyzers are Acting as a Restraint for Hematology Reagents Market 35

6.7 Immunohematology, Global, Revenue ($m), Historic, 2003–2010 36

6.8 Immunohematology, Global, Revenue ($m), Forecast, 2010–2017 37

6.9 Immunohematology, Market Dynamics 38

6.9.1 Market Driver: Increasing Awareness of Blood Donation Resulting in ABO Typing and Antibody Detection is Driving the Immunohematology Market 38

6.9.2 Market Restraint: Immunohematology Market is Affected by Lack of Skilled Workers and Infrastructure 38

6.10 Hematology Rapid Tests, Global, Revenue ($m), Historic, 2003–2010 39

6.11 Hematology Rapid Tests, Global, Revenue ($m), Forecast, 2010–2017 40

6.12 Hematology Rapid Tests, Market Dynamics 41

6.12.1 Market Driver: Increasing Anemia Disease Population is Driving the Hematology Rapid Tests Diagnostic Market 41

6.12.2 Market Restraint: Automated and POCT Devices are Expected to Replace Rapid Test Kits as a Preferred Choice of Hematology Rapid Tests 41

6.13 Hematology Analyzers, Global, Revenue ($m), Historic, 2003–2010 42

6.14 Hematology Analyzers, Global, Revenue ($m), Forecast, 2010–2017 43

6.15 Hematology Analyzers, Market Dynamics 44

6.15.1 Market Driver: Automation and High Volume Testing is Acting as a Driver for the Market of Hematology Analyzers 44

6.15.2 Market Restraint: High Pricing has a Negative Impact on the Acceptance of Automated Hematology Analyzers 44

6.16 Hematology Cell Counters, Global, Revenue ($m), Historic, 2003–2010 44

6.17 Hematology Cell Counters, Global, Revenue ($m), Forecast, 2010–2017 46

6.18 Hematology Cell Counters, Market Dynamics 47

6.18.1 Market Driver: Manual Blood Counting Chambers and Hemoglobinometers are still in Demand in Rural Diagnostic Centers of Countries such as India 47

6.18.2 Market Restraint: Automated Hematology Analyzers are Expected to Replace Manual Counting Chambers as a Preferred Choice of Hematology Cell Counters 47

7 Hematology Market, by Country, Revenue ($m), 2003–2017 48

7.1 Hematology Market, the US, Revenue ($m), Historic, 2003–2010 48

7.2 Hematology Market, the US, Revenue ($m), Forecast, 2010–2017 49

7.3 Hematology Market, Canada, Revenue ($m), Historic, 2003–2010 50

7.4 Hematology Market, Canada, Revenue ($m), Forecast, 2010–2017 51

7.5 Hematology Market, the UK, Revenue ($m), Historic, 2003–2010 52

7.6 Hematology Market, the UK, Revenue ($m), Forecast, 2010–2017 53

7.7 Hematology Market, Germany, Revenue ($m), Historic, 2003–2010 54

7.8 Hematology Market, Germany, Revenue ($m), Forecast, 2010–2017 55

7.9 Hematology Market, France, Revenue ($m), Historic, 2003–2010 56

7.10 Hematology Market, France, Revenue ($m), Forecast, 2010–2017 57

7.11 Hematology Market, Italy, Revenue ($m), Historic, 2003–2010 58

7.12 Hematology Market, Italy, Revenue ($m), Forecast, 2010–2017 59

7.13 Hematology Market, Spain, Revenue ($m), Historic, 2003–2010 60

7.14 Hematology Market, Spain, Revenue ($m), Forecast, 2010–2017 61

7.15 Hematology Market, Japan, Revenue ($m), Historic, 2003–2010 62

7.16 Hematology Market, Japan, Revenue ($m), Forecast, 2010–2017 63

7.17 Hematology Market, China, Revenue ($m), Historic, 2003–2010 63

7.18 Hematology Market, China, Revenue ($m), Forecast, 2010–2017 65

7.19 Hematology Market, India, Revenue ($m), Historic, 2003–2010 66

7.20 Hematology Market, India, Revenue ($m), Forecast, 2010–2017 67

7.21 Hematology Market, Australia, Revenue ($m), Historic, 2003–2010 68

7.22 Hematology Market, Australia, Revenue ($m), Forecast, 2010–2017 69

7.23 Hematology Market, Brazil, Revenue ($m), Historic, 2003–2010 70

7.24 Hematology Market, Brazil, Revenue ($m), Forecast, 2010–2017 71

8 Hematology Market: Strategic Competitive Assessment 72

8.1 Hematology Market, Key Market Participants 73

8.1.1 Beckman Coulter, Inc. 73

8.1.2 Sysmex Corporation 77

8.1.3 F. Hoffmann-La Roche Ltd. 80

8.1.4 Siemens Healthcare 84

8.1.5 Abbott Laboratories 87

9 Hematology Market: Key Marketed Products 90

9.1 The i-STAT System – Hand Held Hematology Analyzer by Abbott Laboratories 90

9.1.1 Product Description 90

9.1.2 Features and Benefits 90

9.2 Cobas b 221 System by Roche Diagnostics 91

9.2.1 Product Description 91

9.2.2 Features and Benefits 91

9.3 XE-AlphaN Automated Hematology System by Sysmex Corporation. 92

9.3.1 Product Description 92

9.3.2 Features and Benefits 92

9.4 UniCel DxH 800 Coulter Cellular Analysis System by Beckman Coulter, Inc. 93

9.4.1 Product Description 93

9.4.2 Features, Advantages and Benefits 93

9.5 PFA-100 Hemostasis System by Siemens Healthcare 94

9.5.1 Product Description 94

9.5.2 Features and Benefits 94

10 Hematology Market: Strategic Pipeline Assessment 95

10.1 Hematology Market: Pipeline Products Summary 95

10.2 Profiles of Promising Hematology Products Under Clinical Development 96

10.2.1 BrightSPOT Hematology Analyzer by Beacon Biotechnology 96

10.2.2 Point of Care Testing Device by Biomerieux Sa 97

10.2.3 BC-6800 Hematology Analyzer by Mindray Medical International Limited 97

10.2.4 Cobas b 123 Point of Care (POC) blood gas System by Roche Diagnostics Limited 98

10.2.5 ADVIA 120 Hematology System –IRF, MPC and MPM Tests by Siemens Healthcare 99

11 Hematology Market: Mergers and Acquisitions (M&A) Landscape 100

11.1 Hematology Market: Key Acquisitions, 2007–2010 102

11.1.1 Danaher to Acquire Beckman Coulter, Inc. for $6.8 Billion 102

11.1.2 Erba Diagnostics Mannheim Acquires Diasis Diagnostic Systems 102

11.1.3 Bio-Rad Laboratories Completes Acquisition of Medical Diagnostics Segment from Biotest 103

11.1.4 Grifols Acquires Medion Diagnostics 103

11.1.5 Danaher Completes Acquisition of Genetix Group 104

11.1.6 CCS Capital Acquires Beijing Biochem Hengye Science & Technology Development Co., Ltd. 104

12 Appendix 105

12.1 Definitions 105

12.1.1 Hematology 105

12.1.2 Hemostasis 105

12.1.3 Hematology Reagents 106

12.1.4 Immunohematology 106

12.1.5 Hematology Rapid Tests 106

12.1.6 Hematology Analyzers 106

12.1.7 Hematology Cell Counters 106

12.2 Acronyms 107

12.3 Sources 108

12.4 Research Methodology 108

12.5 Secondary Research 108

12.6 Primary Research 109

12.7 Models 109

12.8 Forecasts 109

12.9 Expert Panels 110

12.10 GlobalData Consulting 110

12.11 Contact Us 110

12.12 Disclaimer 110

1.1 List of Tables

Table 1: Hematology Market, Global, Revenue ($m), 2003–2010 16

Table 2: Hematology Market, Global, Revenue ($m), 2010–2017 17

Table 3: Hematology Market, Emerging Economies (China, India, Brazil), Revenue ($m), 2003–2017 22

Table 4: Projected Percentage of the US Population Aged 65 and Over, 2000–2050 25

Table 5: Hematology Market, Global, Company Share (%), 2009 29

Table 6: Hemostasis Market, Global, Revenue ($m), 2003–2010 30

Table 7: Hemostasis Market, Global, Revenue ($m), 2010–2017 31

Table 8: Hematology Reagents Market, Global, Revenue ($m), 2003–2010 33

Table 9: Hematology Reagents Market, Global, Revenue ($m), 2010–2017 34

Table 10: Immunohematology Market, Global, Revenue ($m), 2003–2010 36

Table 11: Immunohematology Market, Global, Revenue ($m), 2010–2017 37

Table 12: Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010 39

Table 13: Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017 40

Table 14: Hematology Analyzers Market, Global, Revenue ($m), 2003–2010 42

Table 15: Hematology Analyzers Market, Global, Revenue ($m), 2010–2017 43

Table 16: Hematology Cell Counters Market, Global, Revenue ($m), 2003–2010 45

Table 17: Hematology Cell Counters Market, Global, Revenue ($m), 2010–2017 46

Table 18: Hematology Market, the US, Revenue ($m), 2003–2010 48

Table 19: Hematology Market, the US, Revenue ($m), 2010–2017 49

Table 20: Hematology Market, Canada, Revenue ($m), 2003–2010 50

Table 21: Hematology Market, Canada, Revenue ($m), 2010–2017 51

Table 22: Hematology Market, the UK, Revenue ($m), 2003–2010 52

Table 23: Hematology Market, the UK, Revenue ($m), 2010–2017 53

Table 24: Hematology Market, Germany, Revenue ($m), 2003–2010 54

Table 25: Hematology Market, Germany, Revenue ($m), 2010–2017 55

Table 26: Hematology Market, France, Revenue ($m), 2003–2010 56

Table 27: Hematology Market, France, Revenue ($m), 2010–2017 57

Table 28: Hematology Market, Italy, Revenue ($m), 2003–2010 58

Table 29: Hematology Market, Italy, Revenue ($m), 2010–2017 59

Table 30: Hematology Market, Spain, Revenue ($m), 2003–2010 60

Table 31: Hematology Market, Spain, Revenue ($m), 2010–2017 61

Table 32: Hematology Market, Japan, Revenue ($m), 2003–2010 62

Table 33: Hematology Market, Japan, Revenue ($m), 2010–2017 63

Table 34: Hematology Market, China, Revenue ($m), 2003–2010 64

Table 35: Hematology Market, China, Revenue ($m), 2010–2017 65

Table 36: Hematology Market, India, Revenue ($m), 2003–2010 66

Table 37: Hematology Market, India, Revenue ($m), 2010–2017 67

Table 38: Hematology Market, Australia, Revenue ($m), 2003–2010 68

Table 39: Hematology Market, Australia, Revenue ($m), 2010–2017 69

Table 40: Hematology Market, Brazil, Revenue ($m), 2003–2010 70

Table 41: Hematology Market, Brazil, Revenue ($m), 2010–2017 71

Table 42: Hematology Marketed Products, Beckman Coulter, Inc., 2011 73

Table 43: Beckman Coulter, Inc., Pipeline Products, 2011 74

Table 44: Hematology Marketed Products, Sysmex Corporation, 2011 77

Table 45: Hematology Marketed Products, F. Hoffmann-La Roche Ltd., 2011 81

Table 46: F. Hoffmann-La Roche Ltd., Pipeline Products, 2011 81

Table 47: Hematology Marketed Products, Siemens Healthcare, 2011 84

Table 48: Siemens Healthcare, Pipeline Products, 2011 85

Table 49: Hematology Marketed Products, Abbott Laboratories, 2011 87

Table 50: i-STAT System – Hand Held Hematology Analyzer, Features and Benefits 90

Table 51: Cobas b 221 system, Features and Benefits 91

Table 52: XE-AlphaN Automated Hematology System, Features and Benefits 92

Table 53: UniCel DxH 800 Coulter Cellular Analysis System, Features and Benefits 93

Table 54: PFA-100 Hemostasis System, Features and Benefits 94

Table 55: Hematology Market, Global, Pipeline Assessment, by category, 2011 95

Table 56: BrightSPOT Hematology Analyzer, Product Status, 2011 96

Table 57: Point Of Care Testing Device, Product Status, 2011 97

Table 58: BC-6800 Hematology Analyzer, Product Status, 2011 97

Table 59: Cobas b 123 POC System, Product Status, 2011 98

Table 60: Advia 2120 Hematology System - IRF, MPC, MPM Tests, Product Status, 2011 99

Table 61: Hematology Market, Mergers and Acquisitions, by Volume, Global, 2007–2011* 101

1.2 List of Figures

Figure 1: Hematology Market, Global, Revenue ($m), 2003–2010 15

Figure 2: Hematology Market, Global, Revenue ($m), 2010–2017 16

Figure 3: Hematology, Market Dynamics, Global 20

Figure 4: US Healthcare Insurance System, 2011 21

Figure 5: Essential Components of Diagnosis Related Group (DRG) System 23

Figure 6: Projected Percentage of the US Population Aged 65 and Over, 2000–2050 25

Figure 7: Hematology Market, Global, Company Share (%), 2009 29

Figure 8: Hemostasis Market, Global, Revenue ($m), 2003–2010 30

Figure 9: Hemostasis Market, Global, Revenue ($m), 2010–2017 31

Figure 10: Hematology Reagents Market, Global, Revenue ($m), 2003–2010 33

Figure 11: Hematology Reagents Market, Global, Revenue ($m), 2010–2017 34

Figure 12: Immunohematology Market, Global, Revenue ($m), 2003–2010 36

Figure 13: Immunohematology Market, Global, Revenue ($m), 2010–2017 37

Figure 14: Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010 39

Figure 15: Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017 40

Figure 16: Hematology Analyzers Market, Global, Revenue ($m), 2003–2010 42

Figure 17: Hematology Analyzers Market, Global, Revenue ($m), 2010–2017 43

Figure 18: Hematology Cell Counters Market, Global, Revenue ($m), 2003–2010 44

Figure 19: Hematology Cell Counters Market, Global, Revenue ($m), 2010–2017 46

Figure 20: Hematology Market, the US, Revenue ($m), 2003–2010 48

Figure 21: Hematology Market, the US, Revenue ($m), 2010–2017 49

Figure 22: Hematology Market, Canada, Revenue ($m), 2003–2010 50

Figure 23: Hematology Market, Canada, Revenue ($m), 2010–2017 51

Figure 24: Hematology Market, the UK, Revenue ($m), 2003–2010 52

Figure 25: Hematology Market, the UK, Revenue ($m), 2010–2017 53

Figure 26: Hematology Market, Germany, Revenue ($m), 2003–2010 54

Figure 27: Hematology Market, Germany, Revenue ($m), 2010–2017 55

Figure 28: Hematology Market, France, Revenue ($m), 2003–2010 56

Figure 29: Hematology Market, France, Revenue ($m), 2010–2017 57

Figure 30: Hematology Market, Italy, Revenue ($m), 2003–2010 58

Figure 31: Hematology Market, Italy, Revenue ($m), 2010–2017 59

Figure 32: Hematology Market, Spain, Revenue ($m), 2003–2010 60

Figure 33: Hematology Market, Spain, Revenue ($m), 2010–2017 61

Figure 34: Hematology Market, Japan, Revenue ($m), 2003–2010 62

Figure 35: Hematology Market, Japan, Revenue ($m), 2010–2017 63

Figure 36: Hematology Market, China, Revenue ($m), 2003–2010 63

Figure 37: Hematology Market, China, Revenue ($m), 2010–2017 65

Figure 38: Hematology Market, India, Revenue ($m), 2003–2010 66

Figure 39: Hematology Market, India, Revenue ($m), 2010–2017 67

Figure 40: Hematology Market, Australia, Revenue ($m), 2003–2010 68

Figure 41: Hematology Market, Australia, Revenue ($m), 2010–2017 69

Figure 42: Hematology Market, Brazil, Revenue ($m), 2003–2010 70

Figure 43: Hematology Market, Brazil, Revenue ($m), 2010–2017 71

Figure 44: Hematology Market, Competitive Assessment, 2011 72

Figure 45: Beckman Coulter, Inc., SWOT Analysis, 2011 75

Figure 46: Sysmex Corporation, SWOT Analysis, 2011 79

Figure 47: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2011 82

Figure 48: Siemens Healthcare, SWOT Analysis, 2011 85

Figure 49: Abbott Laboratories, SWOT Analysis, 2011 88

Figure 50: Hematology Market, Mergers and Acquisitions, by Value and Volume, Global, 2007–2011* 100Beckman Coulter, Inc.

Sysmex Corporation

F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Abbott Laboratories

To order this report:

: Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com